$FREQ Frequency Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Frequency Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Frequency Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Frequency Therapeutics, Inc. for free.

CIK Number: 0001703647
IRS Number: 472324450
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FREQ
Company Address: 19 PRESIDENTIAL WAY, SUITE 203 WOBURN 01801
Phone number: 781-315-4600

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The firm's progenitor cell activation approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Frequency Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Arnold Wendy SChief People Officer00Apr 22 202118 days ago
Bookman MichaelGeneral Counsel and Secretary00Apr 22 202118 days ago
Hilt Dana CharlesChief Medical Officer00Apr 22 202118 days ago
LeBel CarlChief Development Officer00Apr 22 202118 days ago
Loose Christopher R.Chief Scientific Officer31,7820shares bought: 13,416 / shares sold: -130,500 STRONG SELLApr 22 202118 days ago
MARCUS JOEL SDirector307,1160shares bought: 2,033,521 / shares sold: -82,509 STRONG BUYMar 29 20211 month ago
McCubbin QuentinChief Manufacturing Officer00Apr 22 202118 days ago
PFREUNDSCHUH PETER P.Chief Financial Officer00Apr 22 202118 days ago

View all Frequency Therapeutics, Inc. insiders.

Frequency Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 22 2021FREQFrequency Therapeu ...McCubbin QuentinChief Manufacturing ...Option ExerciseA0.0035,000035,000
Apr 22 2021FREQFrequency Therapeu ...PFREUNDSCHUH PETER P.Chief Financial Off ...Option ExerciseA0.0030,000030,000
Apr 22 2021FREQFrequency Therapeu ...Arnold Wendy SChief People Office ...Option ExerciseA0.0030,000030,000
Apr 22 2021FREQFrequency Therapeu ...Hilt Dana CharlesChief Medical Offic ...Option ExerciseA0.0030,000030,000
Apr 22 2021FREQFrequency Therapeu ...LeBel CarlChief Development O ...Option ExerciseA0.0030,000030,000
Apr 22 2021FREQFrequency Therapeu ...Loose Christopher R.Chief Scientific Of ...Option ExerciseA0.0030,000030,000
Apr 22 2021FREQFrequency Therapeu ...Bookman MichaelGeneral Counsel and ...Option ExerciseA0.0030,000030,000
Mar 29 2021FREQFrequency Therapeu ...MARCUS JOEL SDirectorOption ExerciseM3.3737,116125,0810
Mar 29 2021FREQFrequency Therapeu ...MARCUS JOEL SDirectorBuyM3.3737,116125,081307,116270 K to 307.1 K (+13.75 %)
Feb 10 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOOption ExerciseM0.6116,55410,098171,441
Feb 10 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOSellS57.505,518317,285308,086313.6 K to 308.1 K (-1.76 %)
Feb 10 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOSellS55.005,518303,490313,604319.1 K to 313.6 K (-1.73 %)
Feb 10 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOSellS52.505,518289,695319,122324.6 K to 319.1 K (-1.70 %)
Feb 10 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOBuyM0.6116,55410,098324,640308.1 K to 324.6 K (+5.37 %)
Feb 05 2021FREQFrequency Therapeu ...Lucchino David L.President and CEOOption ExerciseM0.6111,0366,732187,995

View all Frequency Therapeutics, Inc. insider transactions.